Close

PhaseRx (PZRX) Spikes Higher on EU Orphan Drug Status

December 15, 2017 10:22 AM EST Send to a Friend
PhaseRx (NASDAQ: PZRX) spikes higher following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login